Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2018

Open Access 01-12-2018 | Research article

Using motivational techniques to reduce cardiometabolic risk factors in long term psychiatric inpatients: a naturalistic interventional study

Authors: Petter Andreas Ringen, Ragnhild S. Falk, Bjørnar Antonsen, Ann Faerden, Asgeir Mamen, Eline B. Rognli, Dag K. Solberg, Egil W. Martinsen, Ole A. Andreassen

Published in: BMC Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

People with severe mental illness have markedly reduced life expectancy; cardiometabolic disease is a major cause. Psychiatric hospital inpatients have elevated levels of cardiometabolic risk factors and are to a high degree dependent of the routines and facilities of the institutions. Studies of lifestyle interventions to reduce cardiometabolic risk in psychiatric inpatients are few. The current study aimed at assessing the feasibility and effects of a lifestyle intervention including Motivational Interviewing (MI) on physical activity levels, cardiometabolic risk status and mental health status in psychotic disorder inpatients.

Methods

Prospective naturalistic intervention study of 83 patients at long term inpatient psychosis treatment wards in South-Eastern Norway. Patients were assessed 3–6 months prior to, at start and 6 months after a life-style intervention program including training of staff in MI, simple changes in routines and improvements of facilities for physical exercise. Assessments were done by clinical staff and included level of physical activity, motivation, life satisfaction, symptom levels (MADRS, AES-C, PANSS, and GAF) as well as anthropometric and biochemical markers of cardiometabolic risk. A mixed model was applied to analyze change over time.

Results

A total of 88% of patients received MI interventions, with a mean of 2.5 MI interventions per week per patient. The physical activity level was not increased, but activity level was positively associated with motivation and negatively associated with positive symptoms. Triglyceride levels and number of smokers were significantly reduced and a significant decrease in symptom levels was observed.

Conclusions

The current results suggest that a simple, low cost life-style intervention program focusing on motivational change is feasible and may reduce symptoms and improve lifestyle habits in psychosis patients in long term treatment facilities. Similar programs may easily be implemented in other psychiatric hospitals.

Trial registration

ClinicalTrials.​gov. NCT03528278, date of registration: 05/16/2018 (retrospectively registered).
Appendix
Available only for authorised users
Literature
1.
Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137.CrossRefPubMedPubMedCentral
2.
Petersen L, Sorensen TI. Studies based on the Danish adoption register: schizophrenia, BMI, smoking, and mortality in perspective. Scand J Public Health. 2011;39(Suppl 7):191–5.CrossRefPubMed
3.
McCreadie R. Use of drugs, alcohol and tobacco by people with schizophrenia: case--control study. British J Psychiatry. 2002;181(4):321–5.CrossRef
4.
Beary M, Hodgson R, Wildgust HJ. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J Psychopharmacol. 2012;26(Suppl 5):52–61.CrossRefPubMed
5.
McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. British J Psychiatry. 2003;183(6):534–9.CrossRef
6.
Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(Suppl 1):1–93.PubMed
7.
Tenback D, Pijl B, Smeets H, Os J, Harten P. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study. J Clin Psychopharmacol. 2012;32(1):31–5.CrossRefPubMed
8.
Kahl KG, Westhoff-Bleck M, Krüger THC. Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system. Vasc Pharmacol. 2018;100:20–5.CrossRef
9.
Mann JI. Nutrition recommendations for the treatment and prevention of type 2 diabetes and the metabolic syndrome: an evidenced-based review. Nutr Rev. 2006;64(9):422–7.CrossRefPubMed
10.
Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142(6):1009–18.CrossRefPubMedPubMedCentral
11.
Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288(20):2569–78.CrossRefPubMed
12.
Pagels P, Raustorp A, Archer T, et al. Influence of moderate, daily physical activity upon body composition and blood lipid profile in Swedish adults. J Phys Act Health. 2011;9(6):867–74.CrossRefPubMed
13.
Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani RV. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc. 2009;84(4):373–83.CrossRefPubMedPubMedCentral
14.
Wildgust HJ, Beary M. Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? J Psychopharmacol. 2010;24(Suppl 4):37–50.CrossRefPubMedPubMedCentral
15.
Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015;45(7):1343–61.CrossRefPubMed
16.
Firth J, Rosenbaum S, Stubbs B, Gorczynski P, Yung AR, Vancampfort D. Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis. Psychol Med. 2016;46(14):2869–81.CrossRefPubMedPubMedCentral
17.
Soundy A, Stubbs B, Probst M, Hemmings L, Vancampfort D. Barriers to and facilitators of physical activity among persons with schizophrenia: a survey of physical therapists. Psychiatr Serv. 2014;65(5):693–6.CrossRefPubMed
18.
Cohen R, Florin I, Grusche A, Meyer-Osterkamp S, Sell H. The introduction of a token economy in a psychiatric ward with extremely withdrawn chronic schizophrenics. Behav Res Ther. 1972;10(1):69–74.CrossRefPubMed
19.
O'Brien F, Azrin NH, Henson K. Increased communications of chronic mental patients by reinforcement and by response priming. J Appl Behav Anal. 1969;2(1):23–9.CrossRefPubMedPubMedCentral
20.
Beebe LH, Smith K, Burk R, McIntyre K, Dessieux O, Tavakoli A, et al. Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disorders. Community Ment Health J. 2011;47(6):628–36.CrossRefPubMed
21.
Daumit GL, Dalcin AT, Jerome GJ, Young DR, Charleston J, Crum RM, et al. A behavioral weight loss intervention for persons with serious mental illness in psychiatric rehabilitation centers. Int J Obes. 2011;35:1114-23.
22.
Ganguli R. Behavioral therapy for weight loss in patients with schizophrenia. J Clin Psychiatry. 2007;68(Suppl 4):19–25.PubMed
23.
Methapatara W, Srisurapanont M. Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: a 12-week, randomized, controlled trial. Psychiatry Clin Neurosci. 2011;65(4):374–80.CrossRefPubMed
24.
Miller WR, Rollnick S. Motivational interviewing: helping people change. New York: Guilford press; 2012.
25.
Knight KM, McGowan L, Dickens C, Bundy C. A systematic review of motivational interviewing in physical health care settings. Br J Health Psychol. 2006;11(2):319–32.CrossRefPubMed
26.
Martins RK, McNeil DW. Review of motivational interviewing in promoting health behaviors. Clin Psychol Rev. 2009;29(4):283–93.CrossRefPubMed
27.
Ringen PA, Faerden A, Antonsen B, Falk RS, Mamen A, Rognli EB, et al. Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments. Nordic J Psychiatry. 2018; https://​doi.​org/​10.​1080/​08039488.
28.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental illness. Fourth edition ed. Washington DC: APA; 1994.
29.
De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller H-J. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009; 24(6):412–424.CrossRefPubMed
30.
Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and validity of self-reported physical activity in the Nord-Trondelag health study (HUNT 2). Eur J Epidemiol. 2007;22(6):379–87.CrossRefPubMed
31.
Nes BM, Janszky I, Aspenes ST, et al. Exercise patterns and peak oxygen uptake in a healthy population: the HUNT study. Med Sci Sports Exerc. 2012;44(10):1881–9.CrossRefPubMed
32.
Kurtze N, Rangul V, Hustvedt B-O, et al. Reliability and validity of self-reported physical activity in the Nord-Trøndelag health study — HUNT 1. Scandinavian Journal of Public Health. 2008;36(1):52–61.CrossRefPubMed
33.
Rosenberg M. Society and the adolescent self-image. Princeton, NJ: Princeton University Press; 1965.CrossRef
34.
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.CrossRefPubMed
35.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.CrossRefPubMed
36.
Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the global assessment of functioning-split version. Compr Psychiatry. 2007;48(1):88–94.CrossRefPubMed
37.
Faerden A, Nesvåg R, Barrett EA, Agartz I, Finset A, Friis S, et al. Assessing apathy: The use of the Apathy Evaluation Scale in first episode psychosis. Eur Psychiatry. 2008; 23(1):33–9.
38.
Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38(2):143–62.CrossRefPubMed
39.
Dauwan M, Begemann MJH, Heringa SM, Sommer IE. Exercise improves clinical symptoms, quality of life, global functioning, and depression in schizophrenia: a systematic review and meta-analysis. Schizophr Bull. 2016;42(3):588–99.CrossRefPubMed
40.
Kilbourne AM, Barbaresso MM, Lai Z, Nord KM, Bramlet M, Goodrich DE, et al. Improving physical health in patients with chronic mental disorders: 12-month results from a randomized controlled collaborative care trial. J Clin Psychiatry. 2017;78(1):129–37.CrossRefPubMedPubMedCentral
41.
Speyer H, Brix C, Nørgaard H, Birk M, Karlsen M, Storch Jakobsen A, et al. The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity. World Psychiatry. 2016;15(2):155–65.CrossRefPubMedPubMedCentral
42.
Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J, Hallgren M, et al. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry. 2017;16(3):308–15.CrossRefPubMedPubMedCentral
43.
Urhan M, Ergün C, Aksoy M, Ayer A. Effects of weight loss diet therapy on anthropometric measurements and biochemical variables in schizophrenic patients. Nordic J Psychiatry. 2015;69(5):323–30.CrossRef
44.
Rosenbaum S, Tiedemann A, Sherrington C, Curtis J, Ward PB. Physical activity interventions for people with mental illness: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75(9):964–74.CrossRefPubMed
45.
Baker AL, Richmond R, Kay-Lambkin FJ, Filia SL, Castle D, Williams JM, et al. Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: outcomes to 36 months. Aust N Z J Psychiatry. 2018;52(3):239–52.CrossRefPubMed
46.
Beazley P, Gudjonsson G. Motivating inpatients to engage with treatment: the role of depression and ward atmosphere. Nordic J Psychiatry. 2011;65(2):95–100.CrossRef
47.
Tarpada SP, Morris MT. Physical activity diminishes symptomatic decline in chronic schizophrenia: a systematic review. Psychopharmacol Bull. 2017;47(4):41–52.
Metadata
Title
Using motivational techniques to reduce cardiometabolic risk factors in long term psychiatric inpatients: a naturalistic interventional study
Authors
Petter Andreas Ringen
Ragnhild S. Falk
Bjørnar Antonsen
Ann Faerden
Asgeir Mamen
Eline B. Rognli
Dag K. Solberg
Egil W. Martinsen
Ole A. Andreassen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-018-1832-6

Other articles of this Issue 1/2018

BMC Psychiatry 1/2018 Go to the issue

Research article

Novel online daily diary interventions for nonsuicidal self-injury: a randomized controlled trial

Research article

Preferences for befriending schemes: a survey of patients with severe mental illness

Research article

The effect of financial incentives on patients’ motivation for treatment: results of “Money for Medication,” a randomised controlled trial

Research article

Identity challenges and ‘burden of normality’ after DBS for severe OCD: a narrative case study

Research article

Education and employment status of adults with autism spectrum disorders in Germany – a cross-sectional-survey

Research article

Impact of seasons on stroke-related depression, mediated by vitamin D status